The DOI matches its Crossref record; 24 of the 25 references it cites were found in a registry or an index.
Large C9orf72 Hexanucleotide Repeat Expansions Are Seen in Multiple Neurodegenerative Syndromes and Are More Frequent Than Expected in the UK Population
Open accessAbstract
Hexanucleotide repeat expansions in C9orf72 are a major cause of frontotemporal lobar degeneration (FTLD) and amyotrophic lateral sclerosis (ALS). Understanding the disease mechanisms and a method for clinical diagnostic genotyping have been hindered because of the difficulty in estimating the expansion size. We found 96 repeat-primed PCR expansions: 85/2,974 in six neurodegenerative diseases cohorts (FTLD, ALS, Alzheimer disease, sporadic Creutzfeldt-Jakob disease, Huntington disease-like syndrome, and other nonspecific neurodegenerative disease syndromes) and 11/7,579 (0.15%) in UK 1958 birth cohort (58BC) controls. With the use of a modified Southern blot method, the estimated expansion range (smear maxima) in cases was 800-4,400. Similarly, large expansions were detected in the population controls. Differences in expansion size and morphology were detected between DNA samples from tissue and cell lines. Of those in whom repeat-primed PCR detected expansions, 68/69 were confirmed by blotting, which was specific for greater than 275 repeats. We found that morphology in the expansion smear varied among different individuals and among different brain regions in the same individual. Expansion size correlated with age at clinical onset but did not differ between diagnostic groups. Evidence of instability of repeat size in control families, as well as neighboring SNP and microsatellite analyses, support multiple expansion events on the same haplotype background. Our method of estimating the size of large expansions has potential clinical utility. C9orf72-related disease might mimic several neurodegenerative disorders and, with potentially 90,000 carriers in the United Kingdom, is more common than previously realized.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“For instance, C9orf72 expansion mutations are associated not only with ALS/FTLD, but also with symptoms reminiscent of Parkinson disease, Alzheimer disease, Huntington disease, and corticobasal syndrome, reinforcing the imperfect connection between clinical and molecular phenotypes and emphasizing the need for molecular diagnostics [155–164].”
From Autophagy and ALS: mechanistic insights and therapeutic implications (2022) · cites this paper as [156]
Citations
Cites
DeJesus-Hernandez, M., Mackenzie, I. R., Boeve, B. F., Boxer, A. L., Baker, M., Rutherford, N. J., Nicholson, A. M., Finch, N. A., Flynn, H., Adamson, J., et al. (2011) · Neuron · doi:10.1016/j.neuron.2011.09.011 · Cited by 4,936
A Hexanucleotide Repeat Expansion in C9ORF72 Is the Cause of Chromosome 9p21-Linked ALS-FTD
Renton, A. E., Majounie, E., Waite, A., Simón-Sánchez, J., Rollinson, S., Gibbs, J. R., Schymick, J. C., Laaksovirta, H., van Swieten, J. C., Myllykangas, L., et al. (2011) · Neuron · doi:10.1016/j.neuron.2011.09.010 · Cited by 4,409
Self-citationA high-resolution recombination map of the human genome
Kong, A., Gudbjartsson, D. F., Sainz, J., Jonsdottir, G. M., Gudjonsson, S. A., Richardsson, B., Sigurdardottir, S. L., Barnard, J., Hallbeck, B., Másson, G., et al. (2002) · Nature Genetics · doi:10.1038/ng917 · Cited by 1,750
Majounie, E., Renton, A. E., Mok, K., Dopper, E. G., Waite, A., Rollinson, S., Chiò, A., Restagno, G., Nicolaou, N., Simon-Sanchez, J., et al. (2012) · The Lancet Neurology · doi:10.1016/s1474-4422(12)70043-1 · Cited by 1,210
Self-citationExpandable DNA repeats and human disease
Mirkin, S. M. (2007) · Nature · doi:10.1038/nature05977 · Cited by 934
Gijselinck, I., Langenhove, T. V., van der Zee, J., Sleegers, K., Philtjens, S., Kleinberger, G., Janssens, J., Bettens, K., Cauwenberghe, C. V., Pereson, S., et al. (2011) · The Lancet Neurology · doi:10.1016/s1474-4422(11)70261-7 · Cited by 655
The heritability and genetics of frontotemporal lobar degeneration
Rohrer, J. D., Guerreiro, R., Vandrovcova, J., Uphill, J., Reiman, D., Beck, J., Isaacs, A. M., Authier, A., Ferrari, R., Fox, N. C., et al. (2009) · Neurology · doi:10.1212/wnl.0b013e3181bf997a · Cited by 536
Self-citationSnowden, J. S., Rollinson, S., Thompson, J. C., Harris, J. M., Stopford, C. L., Richardson, A. M. T., Jones, M., Gerhard, A., Davidson, Y. S., Robinson, A., et al. (2012) · Brain · doi:10.1093/brain/awr355 · Cited by 523
Mahoney, C., Beck, J. A., Rohrer, J. D., Lashley, T., Mok, K. Y., Shakespeare, T. J., Yeatman, T., Warrington, E. K., Schott, J. M., Fox, N. C., et al. (2012) · Brain · doi:10.1093/brain/awr361 · Cited by 452
Self-citationSakamoto, N., Chastain, P. D., Parniewski, P., Ohshima, K., Pandolfo, M., Griffith, J. D., & Wells, R. D. (1999) · Molecular Cell · doi:10.1016/s1097-2765(00)80474-8 · Cited by 313
Research works printed but not linked: 1
- Smith, 2012, The C9ORF72 expansion mutation has a single European founder that arose from a background haplotype associated with repeat instability, Dement. Geriatr. Cogn. Disord., 33, 87
Cited by
Sorted by citations
State of play in amyotrophic lateral sclerosis genetics
Renton, A. E., Chiò, A., & Traynor, B. J. (2013) · Nature Neuroscience · doi:10.1038/nn.3584 · Cited by 1,626
C9orf72-mediated ALS and FTD: multiple pathways to disease
Balendra, R., & Isaacs, A. M. (2018) · Nature Reviews Neurology · doi:10.1038/s41582-018-0047-2 · Cited by 715
Self-citationC9orf72 repeat expansions cause neurodegeneration in Drosophila through arginine-rich proteins
Mizielinska, S., Grönke, S., Niccoli, T., Ridler, C. E., Clayton, E. L., Devoy, A., Moens, T., Norona, F. E., Woollacott, I. O. C., Pietrzyk, J., et al. (2014) · Science · doi:10.1126/science.1256800 · Cited by 740
Self-citationTargeting RNA Foci in iPSC-Derived Motor Neurons from ALS Patients with a C9ORF72 Repeat Expansion
Sareen, D., O’Rourke, J. G., Meera, P., Muhammad, A. K. M. G., Grant, S., Simpkinson, M., Bell, S., Carmona, S., Ornelas, L., Sahabian, A., et al. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3007529 · Cited by 670
Protein aggregation in amyotrophic lateral sclerosis
Blokhuis, A. M., Groen, E. J. N., Koppers, M., van den Berg, L. H., & Pasterkamp, R. J. (2013) · Acta Neuropathologica · doi:10.1007/s00401-013-1125-6 · Cited by 607
Mori, K., Arzberger, T., Grässer, F. A., Gijselinck, I., May, S., Rentzsch, K., Weng, S., Schludi, M. H., van der Zee, J., Cruts, M., et al. (2013) · Acta Neuropathologica · doi:10.1007/s00401-013-1189-3 · Cited by 482
Ishiura, H., Shibata, S., Yoshimura, J., Suzuki, Y., Qü, W., Doi, K., Almansour, M. A., Kikuchi, J. K., Taira, M., Mitsui, J., et al. (2019) · Nature Genetics · doi:10.1038/s41588-019-0458-z · Cited by 435
Dipeptide repeat protein pathology in C9ORF72 mutation cases: clinico-pathological correlations
Mackenzie, I. R., Arzberger, T., Kremmer, E., Troost, D., Lorenzl, S., Mori, K., Weng, S.-M., Haass, C., Kretzschmar, H. A., Edbauer, D., et al. (2013) · Acta Neuropathologica · doi:10.1007/s00401-013-1181-y · Cited by 345
Ciura, S., Lattante, S., Le Ber, I., Latouche, M., Tostivint, H., Brice, A., & Kabashi, E. (2013) · Annals of Neurology · doi:10.1002/ana.23946 · Cited by 333
Mizielinska, S., Lashley, T., Norona, F. E., Clayton, E. L., Ridler, C. E., Fratta, P., & Isaacs, A. M. (2013) · Acta Neuropathologica · doi:10.1007/s00401-013-1200-z · Cited by 317
Self-citationExpansions of intronic TTTCA and TTTTA repeats in benign adult familial myoclonic epilepsy
Ishiura, H., Doi, K., Mitsui, J., Yoshimura, J., Matsukawa, M. K., Fujiyama, A., Toyoshima, Y., Kakita, A., Takahashi, H., Suzuki, Y., et al. (2018) · Nature Genetics · doi:10.1038/s41588-018-0067-2 · Cited by 330
May, S., Hornburg, D., Schludi, M. H., Arzberger, T., Rentzsch, K., Schwenk, B. M., Grässer, F. A., Mori, K., Kremmer, E., Banzhaf‐Strathmann, J., et al. (2014) · Acta Neuropathologica · doi:10.1007/s00401-014-1329-4 · Cited by 317
Waite, A. J., Bäumer, D., East, S. Z., Neal, J., Morris, H. R., Ansorge, O., & Blake, D. J. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.01.016 · Cited by 298
van Blitterswijk, M., DeJesus‐Hernandez, M., Niemantsverdriet, E., Murray, M. E., Heckman, M. G., Diehl, N. N., Brown, P. H., Baker, M., Finch, N. A., Bauer, P. O., et al. (2013) · The Lancet Neurology · doi:10.1016/s1474-4422(13)70210-2 · Cited by 266
Frontotemporal lobar degeneration: defining phenotypic diversity through personalized medicine
Irwin, D. J., Cairns, N. J., Grossman, M., McMillan, C. T., Lee, E. B., Deerlin, V. M. V., Lee, V. M. ‐., & Trojanowski, J. Q. (2014) · Acta Neuropathologica · doi:10.1007/s00401-014-1380-1 · Cited by 278
The overlapping genetics of amyotrophic lateral sclerosis and frontotemporal dementia
Abramzon, Y. A., Fratta, P., Traynor, B. J., & Chia, R. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.00042 · Cited by 244
Self-citationon behalf of the BELNEU CONSORTIUM, Gijselinck, I., Van Mossevelde, S., van der Zee, J., Sieben, A., Engelborghs, S., De Bleecker, J., Ivanoiu, A., Deryck, O., Edbauer, D., et al. (2016) · Molecular Psychiatry · doi:10.1038/mp.2015.159 · Cited by 242
Amyotrophic lateral sclerosis: translating genetic discoveries into therapies
Akçimen, F., Lopez, E. R., Landers, J. E., Nath, A., Chiò, A., Chia, R., & Traynor, B. J. (2023) · Nature Reviews Genetics · doi:10.1038/s41576-023-00592-y · Cited by 234
C9orf72 expansions in frontotemporal dementia and amyotrophic lateral sclerosis
Rohrer, J. D., Isaacs, A. M., Mizielinska, S., Mead, S., Lashley, T., Wray, S., Sidle, K. C. L., Fratta, P., Orrell, R. W., Hardy, J., et al. (2015) · The Lancet Neurology · doi:10.1016/s1474-4422(14)70233-9 · Cited by 255
Self-citationDafinca, R., Scaber, J., Ababneh, N. A., Lalic, T., Weir, G. A., Christian, H., Vowles, J., Douglas, A. G. L., Fletcher-Jones, A., Browne, C., et al. (2016) · Stem Cells · doi:10.1002/stem.2388 · Cited by 243
Cady, J., Allred, P., Bali, T., Pestronk, A., Goate, A., Miller, T. M., Mitra, R. D., Ravits, J., Harms, M. B., & Baloh, R. H. (2014) · Annals of Neurology · doi:10.1002/ana.24306 · Cited by 220
Lashley, T., Rohrer, J. D., Mead, S., & Révész, T. (2015) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12250 · Cited by 234
Self-citationG‐quadruplexes: Emerging roles in neurodegenerative diseases and the non‐coding transcriptome
Simone, R., Fratta, P., Neidle, S., Parkinson, G. N., & Isaacs, A. M. (2015) · FEBS Letters · doi:10.1016/j.febslet.2015.05.003 · Cited by 217
Self-citationG‐quadruplex‐binding small molecules ameliorate C9orf72 FTD/ALS pathology in vitro and in vivo
Simone, R., Balendra, R., Moens, T. G., Preza, E., Wilson, K. M., Heslegrave, A., Woodling, N. S., Niccoli, T., Gilbert‐Jaramillo, J., Abdelkarim, S., et al. (2017) · EMBO Molecular Medicine · doi:10.15252/emmm.201707850 · Cited by 212
Self-citationMotor Neuron Susceptibility in ALS/FTD
Ragagnin, A., Shadfar, S., Vidal, M., Jamali, M. S., & Atkin, J. D. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00532 · Cited by 232
C9orf72 expansions are the most common genetic cause of Huntington disease phenocopies
Hensman Moss, D. J., Poulter, M., Beck, J., Hehir, J., Polke, J. M., Campbell, T., Adamson, G., Mudanohwo, E., McColgan, P., Haworth, A., et al. (2014) · Neurology · doi:10.1212/wnl.0000000000000061 · Cited by 203
Self-citationAutophagy and ALS: mechanistic insights and therapeutic implications
Chua, J. P., De Calbiac, H., Kabashi, E., & Barmada, S. J. (2022) · Autophagy · doi:10.1080/15548627.2021.1926656 · Cited by 189
Mann, D. M., Rollinson, S., Robinson, A., Bennion Callister, J., Thompson, J. C., Snowden, J. S., Gendron, T., Petrucelli, L., Masuda-Suzukake, M., Hasegawa, M., et al. (2013) · Acta Neuropathologica Communications · doi:10.1186/2051-5960-1-68 · Cited by 182
Pathogenesis of amyotrophic lateral sclerosis
Morgan, S. L., & Orrell, R. W. (2016) · British Medical Bulletin · doi:10.1093/bmb/ldw026 · Cited by 189
Self-citationFrontotemporal Dementia Associated With the C9ORF72 Mutation: A Unique Clinical Profile
Devenney, E., Hornberger, M., Irish, M., Mioshi, E., Burrell, J., Tan, R., Kiernan, M. C., & Hodges, J. R. (2014) · JAMA Neurology · doi:10.1001/jamaneurol.2013.6002 · Cited by 167
Self-citationC9ORF72: What It Is, What It Does, and Why It Matters
Smeyers, J., Banchi, E.-G., & Latouche, M. (2021) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2021.661447 · Cited by 198
Multiparametric MRI study of ALS stratified for the C9orf72 genotype
Bede, P., Bokde, A. L. W., Byrne, S., Elamin, M., McLaughlin, R. L., Kenna, K. P., Fagan, A. J., Pender, N. P., Bradley, D. G., & Hardiman, O. M. (2013) · Neurology · doi:10.1212/wnl.0b013e31829c5eee · Cited by 171
Dissection of genetic factors associated with amyotrophic lateral sclerosis
Leblond, C. S., Kaneb, H., Dion, P. A., & Rouleau, G. A. (2014) · Experimental Neurology · doi:10.1016/j.expneurol.2014.04.013 · Cited by 175
Current insights into the C9orf72 repeat expansion diseases of the FTLD/ALS spectrum
Cruts, M., Gijselinck, I., Langenhove, T. V., van der Zee, J., & Broeckhoven, C. V. (2013) · Trends in Neurosciences · doi:10.1016/j.tins.2013.04.010 · Cited by 170
Cooper‐Knock, J., Shaw, P. J., & Kirby, J. (2014) · Acta Neuropathologica · doi:10.1007/s00401-014-1251-9 · Cited by 169
The clinical spectrum of sporadic and familial forms of frontotemporal dementia
Woollacott, I., & Rohrer, J. D. (2016) · Journal of Neurochemistry · doi:10.1111/jnc.13654 · Cited by 163
Self-citationXiao, S., MacNair, L., McGoldrick, P., McKeever, P. M., McLean, J. R., Zhang, M., Keith, J. L., Zinman, L. H., Rogaeva, E. A., & Robertson, J. (2015) · Annals of Neurology · doi:10.1002/ana.24469 · Cited by 154
Amyotrophic lateral sclerosis: Problems and prospects
Sreedharan, J., & Brown, R. H. (2013) · Annals of Neurology · doi:10.1002/ana.24012 · Cited by 143
Homozygosity for the C9orf72 GGGGCC repeat expansion in frontotemporal dementia
Fratta, P., Poulter, M., Lashley, T., Rohrer, J. D., Polke, J. M., Beck, J. A., Ryan, N. S., Moss, D. J. H., Mizielinska, S., Waite, A. J., et al. (2013) · Acta Neuropathologica · doi:10.1007/s00401-013-1147-0 · Cited by 144
Self-citationEngineering large animal models of human disease
Whitelaw, B., Sheets, T. P., Lillico, S. G., & Telugu, B. P. V. L. (2015) · The Journal of Pathology · doi:10.1002/path.4648 · Cited by 138
Akimoto, C., Volk, A. E., van Blitterswijk, M., den Broeck, M. V., Leblond, C. S., Lumbroso, S., Camu, W., Neitzel, B., Onodera, O., van Rheenen, W., et al. (2014) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2014-102360 · Cited by 131
Common Molecular Pathways in Amyotrophic Lateral Sclerosis and Frontotemporal Dementia
Weishaupt, J. H., Hyman, T., & Đikić, I. (2016) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2016.07.005 · Cited by 130
Hypermethylation of repeat expanded C9orf72 is a clinical and molecular disease modifier
Russ, J., Liu, E. Y., Wu, K., Neal, D., Suh, E. R., Irwin, D. J., McMillan, C. T., Harms, M. B., Cairns, N. J., Wood, E. M., et al. (2014) · Acta Neuropathologica · doi:10.1007/s00401-014-1365-0 · Cited by 127
Relationship between C9orf72 repeat size and clinical phenotype
Mossevelde, S. V., van der Zee, J., Cruts, M., & Broeckhoven, C. V. (2017) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2017.02.008 · Cited by 128
Phenotypic Heterogeneity of Monogenic Frontotemporal Dementia
Benussi, A., Padovani, A., & Borroni, B. (2015) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2015.00171 · Cited by 129
Nordin, A., Akimoto, C., Wuolikainen, A., Alstermark, H., Jonsson, P., Birve, A., Marklund, S. L., Graffmo, K. S., Forsberg, K., Brännström, T., et al. (2015) · Human Molecular Genetics · doi:10.1093/hmg/ddv064 · Cited by 120
Lehmer, C., Oeckl, P., Weishaupt, J. H., Volk, A. E., Diehl‐Schmid, J., Schroeter, M. L., Lauer, M., Kornhuber, J., Levin, J., Fassbender, K., et al. (2017) · EMBO Molecular Medicine · doi:10.15252/emmm.201607486 · Cited by 118
Davidson, Y. S., Barker, H., Robinson, A., Thompson, J. C., Harris, J., Troakes, C., Smith, B. N., Al‐Saraj, S., Shaw, C. E., Rollinson, S. J., et al. (2014) · Acta Neuropathologica Communications · doi:10.1186/2051-5960-2-70 · Cited by 120
Dols‐Icardo, O., García‐Redondo, A., Rojas‐García, R., Sánchez‐Valle, R., Noguera, A., Gómez‐Tortosa, E., Pástor, P., Hernandez, I., Esteban‐Pérez, J., Suárez‐Calvet, M., et al. (2013) · Human Molecular Genetics · doi:10.1093/hmg/ddt460 · Cited by 116
Disease Mechanisms ofC9ORF72Repeat ExpansionsPreprint
Gendron, T. F., & Petrucelli, L. (2017) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a024224 · Cited by 106
Nicolas, G., Wallon, D., Charbonnier, C., Quenez, O., Rousseau, S., Richard, A.-C., Rovelet-Lecrux, A., Coutant, S., Le Guennec, K., Bacq, D., et al. (2016) · European Journal of Human Genetics · doi:10.1038/ejhg.2015.173 · Cited by 89
Genetic Factors in Mammalian Prion Diseases
Mead, S., Lloyd, S. E., & Collinge, J. (2019) · Annual Review of Genetics · doi:10.1146/annurev-genet-120213-092352 · Cited by 97
Self-citationGenotype–phenotype links in frontotemporal lobar degeneration
Mossevelde, S. V., Engelborghs, S., van der Zee, J., & Broeckhoven, C. V. (2018) · Nature Reviews Neurology · doi:10.1038/s41582-018-0009-8 · Cited by 94
Psychiatric Symptoms in Amyotrophic Lateral Sclerosis: Beyond a Motor Neuron Disorder
Zucchi, E., Ticozzi, N., & Mandrioli, J. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00175 · Cited by 85
Psychiatric Presentations of C9orf72 Mutation: What Are the Diagnostic Implications for Clinicians?
Ducharme, S., Bajestan, S., Dickerson, B. C., & Voon, V. (2017) · The Journal of Neuropsychiatry and Clinical Neurosciences · doi:10.1176/appi.neuropsych.16090168 · Cited by 84
C9orf72-FTD/ALS pathogenesis: evidence from human neuropathological studies
Vatsavayai, S. C., Nana, A. L., Yokoyama, J. S., & Seeley, W. W. (2018) · Acta Neuropathologica · doi:10.1007/s00401-018-1921-0 · Cited by 82
C9ORF72 repeat expansions in cases with previously identified pathogenic mutations
van Blitterswijk, M., Baker, M., DeJesus‐Hernandez, M., Ghidoni, R., Benussi, L., Finger, E. C., Hsiung, G. R., Kelley, B. J., Murray, M. E., Rutherford, N. J., et al. (2013) · Neurology · doi:10.1212/wnl.0b013e3182a8250c · Cited by 83
Anti-sense DNA d(GGCCCC)n expansions in C9ORF72 form i-motifs and protonated hairpins
Kovanda, A., Zalar, M., Šket, P., Plavec, J., & Rogelj, B. (2015) · Scientific Reports · doi:10.1038/srep17944 · Cited by 82
Proudfoot, M. J., Gutowski, N. J., Edbauer, D., Hilton, D. A., Stephens, M., Rankin, J., & Mackenzie, I. R. (2014) · Acta Neuropathologica · doi:10.1007/s00401-014-1245-7 · Cited by 79
Bush, J. A., Aikawa, H., Fuerst, R., Li, Y., Ursu, A., Meyer, S. M., Benhamou, R. I., Chen, J. L., Khan, T., Wagner-Griffin, S., et al. (2021) · Science Translational Medicine · doi:10.1126/scitranslmed.abd5991 · Cited by 77
Šket, P., Pohleven, J., Kovanda, A., Štalekar, M., Župunski, V., Zalar, M., Plavec, J., & Rogelj, B. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.09.012 · Cited by 76
Suh, E. R., Lee, E. B., Neal, D., Wood, E. M., Toledo, J. B., Rennert, L., Irwin, D. J., McMillan, C. T., Krock, B. L., Elman, L. B., et al. (2015) · Acta Neuropathologica · doi:10.1007/s00401-015-1445-9 · Cited by 72
Haase, G., & Rabouille, C. (2015) · Frontiers in Neuroscience · doi:10.3389/fnins.2015.00448 · Cited by 78
Somatic alpha‐synuclein mutations in Parkinson's disease: Hypothesis and preliminary data
Proukakis, C., Houlden, H., & Schapira, A. H. V. (2013) · Movement Disorders · doi:10.1002/mds.25502 · Cited by 74
Self-citationChen, Y., Lin, Z., Chen, X., Cao, B., Wei, Q., Ou, R., Zhao, B., Song, W., Wu, Y., & Shang, H. (2015) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2015.11.016 · Cited by 71
Sense and antisense RNA are not toxic in Drosophila models of C9orf72-associated ALS/FTD
Moens, T. G., Mizielinska, S., Niccoli, T., Mitchell, J. S., Thoeng, A., Ridler, C. E., Grönke, S., Eßer, J., Heslegrave, A., Zetterberg, H., et al. (2018) · Acta Neuropathologica · doi:10.1007/s00401-017-1798-3 · Cited by 72
Self-citationMolecular Mechanisms of Neurodegeneration Related to C9orf72 Hexanucleotide Repeat Expansion
Leko, M. B., Župunski, V., Kirincich, J., Smilović, D., Hortobágyi, T., Hof, P. R., & Šimić, G. (2019) · Behavioural Neurology · doi:10.1155/2019/2909168 · Cited by 73
Hübers, A., Marroquin, N., Schmoll, B., Vielhaber, S., Just, M., Mayer, B., Högel, J., Dorst, J., Mertens, T., Just, W., et al. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2013.11.034 · Cited by 69
Busch, J. I., Unger, T. L., Jain, N., Skrinak, R. T., Charan, R. A., & Chen‐Plotkin, A. S. (2016) · Human Molecular Genetics · doi:10.1093/hmg/ddw127 · Cited by 68
The C9ORF72 hexanucleotide repeat expansion is a rare cause of schizophrenia
Galimberti, D., Reif, A., Dell'Osso, B., Kittel-Schneider, S., Leonhard, C., Herr, A., Palazzo, C., Villa, C., Fenoglio, C., Serpente, M., et al. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2013.12.004 · Cited by 66
Global investigation and meta-analysis of the C9orf72 (G4C2)n repeat in Parkinson disease
GEO-PD Consortium (2014) · VUBIR (Vrije Universiteit Brussel) · doi:10.1212/wnl.0000000000001012
The C9ORF72 expansion mutation: gene structure, phenotypic and diagnostic issues
Woollacott, I., & Mead, S. (2014) · Acta Neuropathologica · doi:10.1007/s00401-014-1253-7 · Cited by 63
Self-citationGoldman, J. S., & Deerlin, V. M. V. (2018) · Molecular Diagnosis & Therapy · doi:10.1007/s40291-018-0347-7 · Cited by 66
Cali, C. P., Patiño, M., Tai, Y. K., Ho, W. Y., McLean, C., Morris, C. M., Seeley, W. W., Miller, B. L., Gaig, C., Vonsattel, J. P., et al. (2019) · Acta Neuropathologica · doi:10.1007/s00401-019-02045-5 · Cited by 64
Clinical Evidence of Disease Anticipation in Families Segregating a C9orf72 Repeat Expansion
Mossevelde, S. V., van der Zee, J., Gijselinck, I., Sleegers, K., Bleecker, J. D., Sieben, A., Vandenberghe, R. R., Langenhove, T. V., Baets, J., Deryck, O., et al. (2017) · JAMA Neurology · doi:10.1001/jamaneurol.2016.4847 · Cited by 62
Fratta, P., Polke, J. M., Newcombe, J., Mizielinska, S., Lashley, T., Poulter, M., Beck, J. A., Preza, E., Devoy, A., Sidle, K. C. L., et al. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.07.037 · Cited by 65
Self-citationG-Quadruplexes in Neurobiology and Virology: Functional Roles and Potential Therapeutic Approaches
Xu, J., Huang, H., & Zhou, X. (2021) · JACS Au · doi:10.1021/jacsau.1c00451 · Cited by 63
Bidirectional nucleolar dysfunction in C9orf72 frontotemporal lobar degeneration
Mizielinska, S., Ridler, C. E., Balendra, R., Thoeng, A., Woodling, N. S., Grässer, F. A., Plagnol, V., Lashley, T., Partridge, L., & Isaacs, A. M. (2017) · Acta Neuropathologica Communications · doi:10.1186/s40478-017-0432-x · Cited by 65
Self-citationAuer‐Grumbach, M., Toegel, S., Schabhüttl, M., Weinmann, D., Chiari, C., Bennett, D., Beetz, C., Klein, D., Andersen, P. M., Böhme, I., et al. (2016) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2016.07.008 · Cited by 59
Genetic models of C9orf72: what is toxic?
Moens, T. G., Partridge, L., & Isaacs, A. M. (2017) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2017.01.006 · Cited by 57
Self-citationNeuron loss and degeneration in the progression of TDP-43 in frontotemporal lobar degeneration
Yousef, A., Robinson, J. L., Irwin, D. J., Byrne, M. D., Kwong, L. K., Lee, E. B., Xu, Y., Xie, S. X., Rennert, L., Suh, E. R., et al. (2017) · Acta Neuropathologica Communications · doi:10.1186/s40478-017-0471-3 · Cited by 55
Benussi, L., Rossi, G., Glionna, M., Tonoli, E., Piccoli, E., Fostinelli, S., Paterlini, A., Flocco, R., Albani, D., Pantieri, R., et al. (2013) · Journal of Alzheimer s Disease · doi:10.3233/jad-131028 · Cited by 58
The impact of histone post-translational modifications in neurodegenerative diseases
Cobos, S. N., Bennett, S. A., & Torrente, M. P. (2018) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2018.10.019 · Cited by 53
Amyotrophic lateral sclerosis: an update on recent genetic insights
Iguchi, Y., Katsuno, M., Ikenaka, K., Ishigaki, S., & Sobue, G. (2013) · Journal of Neurology · doi:10.1007/s00415-013-7112-y · Cited by 56
Intermediate C9orf72 alleles in neurological disorders: does size really matter?
Ng, A. S. L., & Tan, E. (2017) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2017-104752 · Cited by 54
Bourinaris, T., & Houlden, H. (2018) · Movement Disorders Clinical Practice · doi:10.1002/mdc3.12677 · Cited by 58
Self-citationStructural Variants May Be a Source of Missing Heritability in sALS
Theunissen, F., Flynn, L. L., Anderton, R. S., Mastaglia, F. L., Pytte, J., Jiang, L., Hodgetts, S. I., Burns, D. K., Saunders, A. M., Fletcher, S., et al. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.00047 · Cited by 56
Jump from Pre-mutation to Pathologic Expansion in C9orf72
Xi, Z., van Blitterswijk, M., Zhang, M., McGoldrick, P., McLean, J. R., Yunusova, Y., Knock, E., Moreno, D., Sato, C., McKeever, P. M., et al. (2015) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2015.04.016 · Cited by 53
C9orf72 hexanucleotide repeat expansions in Chinese sporadic amyotrophic lateral sclerosis
He, J., Tang, L., Benyamin, B., Shah, S. H., Hemani, G., Liu, R., Ye, S., Liu, X., Ma, Y., Zhang, H., et al. (2015) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2015.06.002 · Cited by 53
The Spectrum of C9orf72-mediated Neurodegeneration and Amyotrophic Lateral Sclerosis
Cooper‐Knock, J., Kirby, J., Highley, J. R., & Shaw, P. J. (2015) · Neurotherapeutics · doi:10.1007/s13311-015-0342-1 · Cited by 58
Unravelling the clinical spectrum and the role of repeat length in C9ORF72 repeat expansions
van der Ende, E. L., Jackson, J. L., White, A. E., Seelaar, H., van Blitterswijk, M., & Swieten, J. C. V. (2021) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2020-325377 · Cited by 52
The Genetics of Monogenic Frontotemporal Dementia
Takada, L. T. (2015) · Dementia & Neuropsychologia · doi:10.1590/1980-57642015dn93000003 · Cited by 56
Keogh, M. J., Wei, W., Wilson, I., Coxhead, J., Ryan, S., Rollinson, S. J., Griffin, H. R., Kurzawa‐Akanbi, M., Santibanez‐Koref, M., Talbot, K., et al. (2016) · Genome Research · doi:10.1101/gr.210609.116 · Cited by 51
Mizielinska, S., Hautbergue, G. M., Gendron, T. F., van Blitterswijk, M., Hardiman, O. M., Ravits, J., Isaacs, A. M., & Rademakers, R. (2025) · The Lancet Neurology · doi:10.1016/s1474-4422(25)00026-2 · Cited by 54
Self-citationStepto, A., Gallo, J., Shaw, C. E., & Hirth, F. (2013) · Acta Neuropathologica · doi:10.1007/s00401-013-1235-1 · Cited by 53
Vatovec, S., Kovanda, A., & Rogelj, B. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.04.015 · Cited by 53
Fournier, C., Barbier, M., Camuzat, A., Anquetil, V., Lattante, S., Clot, F., Cazeneuve, C., Rinaldi, D., Couratier, P., Deramecourt, V., et al. (2018) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2018.09.010 · Cited by 50
Schottlaender, L., Polke, J. M., Ling, H., MacDoanld, N. D., Tucci, A., Nanji, T., Pittman, A. M., de Silva, R., Holton, J. L., Révész, T., et al. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.08.024 · Cited by 49
Self-citationJackson, J. L., Finch, N. A., Baker, M., Kachergus, J. M., DeJesus‐Hernandez, M., Pereira, K. L., Christopher, E. A., Prudencio, M., Heckman, M. G., Thompson, E. A., et al. (2020) · Molecular Neurodegeneration · doi:10.1186/s13024-020-0359-8 · Cited by 51
Brown, D. G., Shorter, J., & Wobst, H. J. (2019) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2019.126942 · Cited by 53
Metadata
- Authors
- Beck, J., Poulter, M., Hensman, D., Rohrer, J. D., Mahoney, C. J., Adamson, G., Campbell, T., Uphill, J., Borg, A., Fratta, P., Orrell, R. W., Malaspina, A., Rowe, J., Brown, J., Hodges, J., Sidle, K., Polke, J. M., Houlden, H., Schott, J. M., Fox, N. C., Rossor, M. N., Tabrizi, S. J., Isaacs, A. M., Hardy, J., Warren, J. D., Collinge, J., & Mead, S.
- Affiliations
- MRC Prion Unit (GB)
- UCL Queen Square Institute of Neurology (GB)
- National Hospital for Neurology and Neurosurgery (GB)
- Queen Mary University of London (GB)
- University of Cambridge (GB)
- Corresponding author
- Mead, Simon
- ORCID
- Venue
- The American Journal of Human Genetics
- Publisher
- Elsevier BV
- Published
- 2013-03
- Volume
- 92
- Issue
- 3
- Pages
- 345-353
- ISSN
- 0002-9297 (ISSN-L)
- PMC
- PMC3591848
- OpenAlex
- W2026340703
- Cited by
- 345
- References
- 25
- Citations by year
- 2026: 4 · 2025: 6 · 2024: 24 · 2023: 24 · 2022: 31 · 2021: 21 · 2020: 20 · 2019: 21 · 2018: 27 · 2017: 21 · 2016: 24 · 2015: 44 · 2014: 41 · 2013: 35
- FWCI
- 30.46
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- The American Journal of Human Genetics (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Funders
- Wellcome Trust (068545/Z/02), 088324, 091673/Z/10/Z, 068545)
- National Institute for Health and Care Research (NF-SI-0512-10033, ACF-2009-18-016, NF-SI-0508-10123)
- Motor Neurone Disease Association (Orrell/Apr11/6075)
- Medical Research Council (MR/J004758/1, MR/J003832/1)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Amyotrophic Lateral Sclerosis Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Genetic Neurodegenerative Diseases
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Keywords
- C9orf72, hexanucleotide repeat expansion, repeat-primed PCR, Southern blot, frontotemporal lobar degeneration, amyotrophic lateral sclerosis, Alzheimer's disease, Creutzfeldt-Jakob disease, repeat instability, haplotypes, age of onset, 1958 British birth cohort
- MeSH terms
- C9orf72 Protein, Amyotrophic Lateral Sclerosis, Brain, DNA, United Kingdom, Haplotypes, Humans, Nerve Degeneration, Proteins, Cohort Studies, Microsatellite Repeats, Genetic Predisposition to Disease, Polymorphism, Single Nucleotide, DNA Repeat Expansion, Frontotemporal Lobar Degeneration
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
